AMS:LKFT

Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated
····

Lakefront Biotherapeutics Shares Drop as LKFT Gets Reevaluated

Lakefront Biotherapeutics shares fell 2.7% in Amsterdam and 1.7% in New York on Monday, extending a 15% decline this year. Bank of America disclosed a 9.3% stake as of May 20, mainly through financial instruments. The company holds €2.98 billion in cash but expects heavy spending in 2026 tied to its Gilead-Ouro partnership and cell therapy exit. Shareholders recently approved the Lakefront rebrand and new ticker LKFT.
June 1, 2026

Stock Market Today

  • SRG Global Secures Large Contracts, Boosting Market Momentum
    June 1, 2026, 8:23 PM EDT. SRG Global has announced a significant haul of contracts, signaling strong momentum for the company in its sector. The contract wins are expected to bolster SRG Global's revenue pipeline and reinforce its competitive position. Investors are closely monitoring the developments as the company capitalizes on growing demand in its markets. This surge in contract acquisitions reflects confidence in SRG Global's operational capabilities and strategic direction, potentially impacting its stock performance positively in the near term.